Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Gray market grows for cheap weight-loss drugs imported from China, while some users try small doses of substances not yet ...

The World Health Organization continues its investigation into the origins of COVID-19, with significant information still needed. Concurrently, Americans like Amy Spencer are crafting their own ...

A recent study published in the Journal of the American Dental Association found that Tirzepatide presented a novel strategy ...

That calls the FDA's decision to restrict compounding of tirzepatide "a reckless and arbitrary decision […] to deprive patients of a vital treatment for type 2 diabetes and obesity." ...

Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.